N. Mottet

Phase II study of oxaliplatin versus oxaliplatin combined with infusional 5-fluorouracil in hormone refractory metastatic prostate cancer patients.

S. Culine, J. Droz, J. Misset, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

EAU guidelines on prostate cancer . Part I : screening , diagnosis , and treatment of clinically localised disease

M Bolla, T. H. van der Kwast, T. Wiegel, 2012 .

EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis and local treatment with curative intent

N. Fossati, O. Rouvière, S. Joniau, 2022 .

VALIDATION OF METASTASIS-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN LOCALIZED PROSTATE CANCER IN THE ERA OF DOCETAXEL FOR CASTRATION RESISTANT PROSTATE CANCER.

B. Tombal, K. Fizazi, N. Mottet, 2023, Annals of oncology : official journal of the European Society for Medical Oncology.

Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project

T. D. de Reijke, S. Crouzet, A. Villers, 2016, World Journal of Urology.

A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research.

H. G. van der Poel, T. H. van der Kwast, R. V. D. van den Bergh, 2021, European urology oncology.

Randomized comparison of transurethral electroresection and holmium: YAG laser vaporization for symptomatic benign prostatic hyperplasia.

O. Bourdon, P. Teillac, A. Le Duc, 1999, Journal of endourology.